EFM
E Fund Management Portfolio holdings
AUM
$2.1B
1-Year Return
23.31%
This Quarter Return
-1.53%
1 Year Return
+23.31%
3 Year Return
+155.42%
5 Year Return
–
10 Year Return
–
AUM
$1.26B
AUM Growth
-$105M
(-7.7%)
Cap. Flow
-$59.3M
Cap. Flow
% of AUM
-4.69%
Top 10 Holdings %
Top 10 Hldgs %
60.92%
Holding
343
New
11
Increased
61
Reduced
233
Closed
34
Top Buys
| 1 |
Pinduoduo
PDD
|
+$52.2M |
| 2 |
KE Holdings
BEKE
|
+$28.2M |
| 3 |
TSMC
TSM
|
+$11.8M |
| 4 |
Kanzhun
BZ
|
+$5.71M |
| 5 |
iQIYI
IQ
|
+$4.15M |
Top Sells
| 1 |
Tencent Music
TME
|
+$38.3M |
| 2 |
Trip.com Group
TCOM
|
+$19.3M |
| 3 |
Marvell Technology
MRVL
|
+$14.8M |
| 4 |
JOYY
JOYY Inc. American Depositary Shares
JOYY
|
+$7.98M |
| 5 |
Microsoft
MSFT
|
+$6.65M |
Sector Composition
| 1 | Consumer Discretionary | 37.28% |
| 2 | Technology | 32.43% |
| 3 | Communication Services | 9.6% |
| 4 | Healthcare | 8.37% |
| 5 | Real Estate | 6.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
CoStar Group
CSGP
$37.3B
| $340K | 0.03% |
3,823
-558
| -13% | -$49.6K |
|
|
SWTX
202
DELISTED
SpringWorks Therapeutics
SWTX
| $340K | 0.03% |
12,950
+528
| +4% | +$13.9K |
|
203
Krystal Biotech
KRYS
$4.2B
| $335K | 0.03% |
2,857
-631
| -18% | -$74K |
|
204
Veracyte
VCYT
$2.55B
| $333K | 0.03% |
13,085
-3,422
| -21% | -$87.1K |
|
205
Bank of America
BAC
$366B
| $332K | 0.03% |
11,579
-1,422
| -11% | -$40.8K |
|
206
Electronic Arts
EA
$42B
| $329K | 0.03% |
2,540
-389
| -13% | -$50.4K |
|
207
Arcus Biosciences
RCUS
$1.22B
| $328K | 0.03% |
16,136
-7,199
| -31% | -$146K |
|
208
Avidity Biosciences
RNA
$6.18B
| $327K | 0.03% |
29,464
+11,943
| +68% | +$133K |
|
209
Xcel Energy
XEL
$42.4B
| $321K | 0.03% |
5,162
-755
| -13% | -$47K |
|
210
Bristol-Myers Squibb
BMY
$95.1B
| $317K | 0.03% |
4,953
-471
| -9% | -$30.1K |
|
211
AstraZeneca
AZN
$253B
| $316K | 0.03% |
4,420
-950
| -18% | -$67.9K |
|
212
Fastenal
FAST
$55.3B
| $316K | 0.03% |
10,720
-1,578
| -13% | -$46.5K |
|
213
Linde
LIN
$223B
| $312K | 0.02% |
818
-100
| -11% | -$38.1K |
|
214
Viridian Therapeutics
VRDN
$1.62B
| $312K | 0.02% |
13,122
+3,078
| +31% | +$73.2K |
|
215
Verisk Analytics
VRSK
$38.1B
| $306K | 0.02% |
1,355
-315
| -19% | -$71.1K |
|
|
CERE
216
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $302K | 0.02% |
9,501
-2,431
| -20% | -$77.3K |
|
217
Baker Hughes
BKR
$45B
| $299K | 0.02% |
9,471
-1,409
| -13% | -$44.5K |
|
218
Viking Therapeutics
VKTX
$2.87B
| $298K | 0.02% |
18,403
-12,273
| -40% | -$199K |
|
219
Dynavax Technologies
DVAX
$1.14B
| $297K | 0.02% |
22,959
-7,758
| -25% | -$100K |
|
220
Dollar Tree
DLTR
$20.3B
| $294K | 0.02% |
2,048
-310
| -13% | -$44.5K |
|
221
Medtronic
MDT
$119B
| $294K | 0.02% |
3,340
-395
| -11% | -$34.8K |
|
222
Keysight
KEYS
$29.1B
| $293K | 0.02% |
1,747
-179
| -9% | -$30K |
|
|
BLUE
223
DELISTED
bluebird bio
BLUE
| $291K | 0.02% |
4,430
-177
| -4% | -$11.6K |
|
224
Warner Bros
WBD
$30.6B
| $282K | 0.02% |
22,493
-3,266
| -13% | -$40.9K |
|
225
Constellation Energy
CEG
$93.4B
| $279K | 0.02% |
3,046
-478
| -14% | -$43.8K |
|